SCARSI, Mirko
 Distribuzione geografica
Continente #
EU - Europa 1.821
NA - Nord America 1.181
AS - Asia 268
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
AF - Africa 1
OC - Oceania 1
Totale 3.279
Nazione #
IT - Italia 1.235
US - Stati Uniti d'America 1.177
CN - Cina 196
DE - Germania 162
UA - Ucraina 161
FR - Francia 76
FI - Finlandia 56
GB - Regno Unito 48
HK - Hong Kong 42
IE - Irlanda 26
RU - Federazione Russa 21
IN - India 18
SE - Svezia 14
ES - Italia 7
CA - Canada 4
EU - Europa 4
RO - Romania 4
CH - Svizzera 3
SG - Singapore 3
BE - Belgio 2
BR - Brasile 2
JO - Giordania 2
JP - Giappone 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
AR - Argentina 1
AU - Australia 1
ID - Indonesia 1
IQ - Iraq 1
LU - Lussemburgo 1
MU - Mauritius 1
PL - Polonia 1
TW - Taiwan 1
Totale 3.279
Città #
Fairfield 128
Jacksonville 119
Woodbridge 115
Ann Arbor 105
Ashburn 92
Milan 76
Houston 65
Rome 64
Chandler 61
Wilmington 58
Beijing 56
Seattle 52
Cambridge 50
Princeton 50
Hong Kong 42
Nanjing 40
Helsinki 36
New York 28
Dublin 25
Turin 21
Brescia 17
Nanchang 17
Bologna 16
Florence 15
Des Moines 14
Dearborn 13
Mumbai 13
Torino 12
Padova 11
Hebei 9
Shenyang 9
Changsha 8
Genoa 8
Reggio Nell'emilia 8
Tianjin 8
Verona 8
Jinan 7
Modena 7
Sassari 7
Trento 7
Venice 7
Genova 6
Jiaxing 6
Nürnberg 6
San Diego 6
Shanghai 6
Boardman 5
Duino-Aurisina 5
Ferrara 5
London 5
Perugia 5
Bari 4
Capua 4
Castelnuovo Rangone 4
Catania 4
Cernobbio 4
Cisano Bergamasco 4
Dallas 4
Fermo 4
Kunming 4
Lanzhou 4
Ningbo 4
Palermo 4
Pescara 4
Quart 4
Stra 4
Trieste 4
Altopascio 3
Arcos De La Frontera 3
Bergamo 3
Cagliari 3
Camastra 3
Castel di Lama 3
Cosenza 3
Crotone 3
Desenzano del Garda 3
Ferentino 3
Haikou 3
Lecco 3
Mountain View 3
Napoli 3
Sagrado 3
Scandicci 3
Treia 3
Udine 3
Varallo Pombia 3
Viterbo 3
Acireale 2
Albenga 2
Amman 2
Argenta 2
Argenteuil 2
Aversa 2
Brussels 2
Calolziocorte 2
Campobasso 2
Carrara 2
Caserta 2
Casteltermini 2
Castiglione 2
Totale 1.709
Nome #
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.387
Microvascular Density and Circulating Endothelial Progenitor Cells Before and After Treatment with Incretin Mimetics in Diabetic Patients 143
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 109
Type I interferons in systemic autoimmunity. 101
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis. 101
Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans 100
Impact of in utero environment on the offspring of lupus patients 98
Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases. 97
Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis 95
LA PREDITTIVITA DEGLI ANTICORPI ANTI-RO/SSA-P200 NEL BLOCCO CARDIACO CONGENITO 85
WINTER LUPUS FLARES ARE ASSOCIATED WITH LOWER VITAMIN D LEVELS IN A RETROSPECTIVE LONGITUDINAL STUDY OF ITALIAN PATIENTS 80
DECREASED TITER OF ANTI-CCP ANTIBODIES AND RHEUMATOID FACTOR AND REDUCTION OF POSTSWITCH MEMORY B CELLS AFTER ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS 79
RELATIONSHIP BETWEEN MICROVASCULAR T REGULATORY LYMPHOCYTES AND CIRCULATING LYMPHOCYTES 77
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept 76
THE EFFECTS ON T-CELL IMMUNE PHENOTYPE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH TWO DIFFERENT REGIMENS OF VITAMIN D SUPPLEMENTATION 73
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease 68
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al 68
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase 67
Pregnancy in systemic sclerosis: a prospective study 63
REDUCTION OF PERIPHERAL BLOOD G-IFN AND IL-17 PRODUCING T CELLS AFTER THERAPY WITH ABATACEPT FOR RHEUMATOID ARTHRITIS 62
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 61
Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune disease. 54
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 50
REDUCTION OF T-CELL CLONAL EXPANSION IN RHEUMATOID ARTHRITIS PATIENTS AFTER 12 MONTHS OF ABATACEPT TREATMENT. 50
LOW NUMBERS OF CIRCULATING CD28 NEGATIVE T CELLS MAY BE A PREDICTIVE FACTOR OF A GOOD CLINICAL RESPONSE TO ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS 49
LA RIDUZIONE DEL NUMERO ASSOLUTO DELLE CELLULE T CD8+CD28- CIRCOLANTI ENTRO 6 MESI DI TERAPIA CON ABATACEPT COME FATTORE PREDDITIVO DI BUONA RISPOSTA CLINICA A 1 ANNO 41
Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial 13
Totale 3.347
Categoria #
all - tutte 9.782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.782


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019122 0 0 0 0 0 0 0 0 0 0 58 64
2019/2020704 102 32 37 65 40 79 65 69 35 105 34 41
2020/2021606 24 75 49 79 19 64 31 56 63 64 59 23
2021/2022484 22 47 13 40 20 63 40 44 34 52 48 61
2022/2023397 46 10 16 24 38 68 13 37 68 16 35 26
2023/2024277 21 9 25 36 21 58 16 23 55 7 6 0
Totale 3.347